Company intelligence / Profile preview

Kwality Pharmaceuticals

Amritsar, Punjab, India

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Kwality Pharmaceuticals has a strong commercial portfolio of over 600 registered products globally and a robust pipeline of complex injectables, biosimilars, and niche generics. The company recently achieved proof of concept for its first biosimilar (erythropoietin), with biosimilar etanercept and alteplase in development. They are leaders in small molecules and advanced injectable technologies, with recent approvals expanding their international market reach, especially in Latin America and regulated markets[2][5][8][6].

Therapeutic areas: OncologyHematologyImmunologyCardiovascular
Modalities: Small moleculePeptidesProteinLiposomal formulationMicrospheresRecombinant proteinBiologic
Industry: Biotech

Beyond the preview

Go deeper on Kwality Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kwality Pharmaceuticals.

Explore the full profile